Developer site: The content shown here is test data.

Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Back to skin conditions

Fibroadenoma historical perspective

Introduction

Overview

Overview

Dupont et al described in 1994 the risk of invasive breast cancer in patients with fibroadenoma. Later in a study with Carter, atypia within a fibroadenoma was assessed for the risk of cancer development. In another study, the excision of a complex fibroadenoma discovered via core biopsy was advised.

Historical Perspective

Historical Perspective

  • In 1994, Dupont et al addressed in their retrospective cohort study that fibroadenoma is associated with a long term risk of invasive breast cancer, with the risk further increased in women with complex fibroadenomas, a family history of breast cancer and those with proliferative disease. Later in a study with Carter in 2001, they found that the presence of atypia within a fibroadenoma cannot foretell the presence of one in the adjacent breast parenchyma. They also found that atypia within a fibroadenoma does not present a relevant risk of development of breast cancer greater than that of a fibroadenoma with no atypia within.[1][2]
  • In 2008, Solar-Levy et al reported the presence of invasive lobular carcinoma in about 1.6% of patients with complex fibroadenomas and advised that any complex fibroadenoma with a high risk lesion on core biopsy should be excised. They also recommended that simple fibroadenomas with a volume growth rate of less than 16% per month (in patients younger than 50 years of age) and less than 13% per month (more than 50 years) should be followed up with imaging studies.[3][4][5]
References

References

  1. ↑ Dupont WD, Page DL, Parl FF, Vnencak-Jones CL, Plummer WD, Rados MS; et al. (1994). “Long-term risk of breast cancer in women with fibroadenoma”. N Engl J Med. 331 (1): 10–5. doi:10.1056/NEJM199407073310103. PMID 8202095.
  2. ↑ Carter BA, Page DL, Schuyler P, Parl FF, Simpson JF, Jensen RA; et al. (2001). “No elevation in long-term breast carcinoma risk for women with fibroadenomas that contain atypical hyperplasia”. Cancer. 92 (1): 30–6. PMID 11443606.
  3. ↑ Sklair-Levy M, Sella T, Alweiss T, Craciun I, Libson E, Mally B (2008). “Incidence and management of complex fibroadenomas”. AJR Am J Roentgenol. 190 (1): 214–8. doi:10.2214/AJR.07.2330. PMID 18094314.
  4. ↑ Sanders LM, Sara R (2015). “The growing fibroadenoma”. Acta Radiol Open. 4 (4): 2047981615572273. doi:10.1177/2047981615572273. PMC 4406922. PMID 25922691.
  5. ↑ Gordon PB, Gagnon FA, Lanzkowsky L (2003). “Solid breast masses diagnosed as fibroadenoma at fine-needle aspiration biopsy: acceptable rates of growth at long-term follow-up”. Radiology. 229 (1): 233–8. doi:10.1148/radiol.2291010282. PMID 14519878.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ifeoma Odukwe, M.D. [2] Haytham Allaham, M.D. [3]